BACKGROUND: Major advances in combat casualty care have led to increased survival of patients with complex extremity trauma. Invasive fungal wound infections (IFIs) are an uncommon, but increasingly recognized, complication following trauma that require greater understanding of risk factors and clinical findings to reduce morbidity. METHODS: The patient population includes US military personnel injured during combat from June 2009 through December 2010. Case definition required wound necrosis on successive debridements with IFI evidence by histopathology and/or microbiology (Candida spp excluded). Case finding and data collected through the Trauma Infectious Disease Outcomes Study utilized trauma registry, hospital records or operative reports, and pathologist review of histopathology specimens. RESULTS: A total of 37 cases were identified: proven (angioinvasion, n=20), probable (nonvascular tissue invasion, n=4), and possible (positive fungal culture without histopathological evidence, n=13). In the last quarter surveyed, rates reached 3.5% of trauma admissions. Common findings include blast injury (100%) during foot patrol (92%) occurring in southern Afghanistan (94%) with lower extremity amputation (80%) and large volume blood transfusion (97.2%). Mold isolates were recovered in 83% of cases (order Mucorales, n=16; Aspergillus spp, n=16; Fusarium spp, n=9), commonly with multiple mold species among infected wounds (28%). Clinical outcomes included 3 related deaths (8.1%), frequent debridements (median, 11 cases), and amputation revisions (58%). CONCLUSIONS: IFIs are an emerging trauma-related infection leading to significant morbidity. Early identification, using common characteristics of patient injury profile and tissue-based diagnosis, should be accompanied by aggressive surgical and antifungal therapy (liposomal amphotericin B and a broad-spectrum triazole pending mycology results) among patients with suspicious wounds.
BACKGROUND: Major advances in combat casualty care have led to increased survival of patients with complex extremity trauma. Invasive fungal wound infections (IFIs) are an uncommon, but increasingly recognized, complication following trauma that require greater understanding of risk factors and clinical findings to reduce morbidity. METHODS: The patient population includes US military personnel injured during combat from June 2009 through December 2010. Case definition required wound necrosis on successive debridements with IFI evidence by histopathology and/or microbiology (Candida spp excluded). Case finding and data collected through the Trauma Infectious Disease Outcomes Study utilized trauma registry, hospital records or operative reports, and pathologist review of histopathology specimens. RESULTS: A total of 37 cases were identified: proven (angioinvasion, n=20), probable (nonvascular tissue invasion, n=4), and possible (positive fungal culture without histopathological evidence, n=13). In the last quarter surveyed, rates reached 3.5% of trauma admissions. Common findings include blast injury (100%) during foot patrol (92%) occurring in southern Afghanistan (94%) with lower extremity amputation (80%) and large volume blood transfusion (97.2%). Mold isolates were recovered in 83% of cases (order Mucorales, n=16; Aspergillus spp, n=16; Fusarium spp, n=9), commonly with multiple mold species among infected wounds (28%). Clinical outcomes included 3 related deaths (8.1%), frequent debridements (median, 11 cases), and amputation revisions (58%). CONCLUSIONS: IFIs are an emerging trauma-related infection leading to significant morbidity. Early identification, using common characteristics of patient injury profile and tissue-based diagnosis, should be accompanied by aggressive surgical and antifungal therapy (liposomal amphotericin B and a broad-spectrum triazole pending mycology results) among patients with suspicious wounds.
Authors: Howard R Champion; John B Holcomb; Mary M Lawnick; Timothy Kelliher; Mary Ann Spott; Michael R Galarneau; Donald H Jenkins; Susan A West; Judy Dye; Charles E Wade; Brian J Eastridge; Lorne H Blackbourne; Ellen Kalin Shair Journal: J Trauma Date: 2010-05
Authors: Brad Spellberg; Ashraf S Ibrahim; Peter V Chin-Hong; Dimitrios P Kontoyiannis; Michele I Morris; John R Perfect; David Fredricks; Eric P Brass Journal: J Antimicrob Chemother Date: 2011-09-20 Impact factor: 5.790
Authors: Kristopher M Paolino; James A Henry; Duane R Hospenthal; Glenn W Wortmann; Joshua D Hartzell Journal: Mil Med Date: 2012-06 Impact factor: 1.437
Authors: Tatjana P Calvano; Peter J Blatz; Todd J Vento; Brian L Wickes; Deanna A Sutton; Elizabeth H Thompson; Christopher E White; Evan M Renz; Duane R Hospenthal Journal: J Clin Microbiol Date: 2011-08-03 Impact factor: 5.948
Authors: Duane R Hospenthal; Kevin K Chung; Kimberly Lairet; Elizabeth H Thompson; Josep Guarro; Evan M Renz; Deanna A Sutton Journal: J Clin Microbiol Date: 2011-08-24 Impact factor: 5.948
Authors: Clinton K Murray; Kenneth Wilkins; Nancy C Molter; Fang Li; Lily Yu; Mary Ann Spott; Brian Eastridge; Lorne H Blackbourne; Duane R Hospenthal Journal: J Trauma Date: 2011-07
Authors: David R Tribble; Nicholas G Conger; Susan Fraser; Todd D Gleeson; Ken Wilkins; Tanya Antonille; Amy Weintrob; Anuradha Ganesan; Lakisha J Gaskins; Ping Li; Greg Grandits; Michael L Landrum; Duane R Hospenthal; Eugene V Millar; Lorne H Blackbourne; James R Dunne; David Craft; Katrin Mende; Glenn W Wortmann; Rachel Herlihy; Jay McDonald; Clinton K Murray Journal: J Trauma Date: 2011-07
Authors: Demetrius Evriviades; Steven Jeffery; Tania Cubison; Graham Lawton; Martin Gill; Deborah Mortiboy Journal: Philos Trans R Soc Lond B Biol Sci Date: 2011-01-27 Impact factor: 6.237
Authors: Sarah P Hammond; Ralf Bialek; Danny A Milner; Eva M Petschnigg; Lindsey R Baden; Francisco M Marty Journal: J Clin Microbiol Date: 2011-04-20 Impact factor: 5.948
Authors: Patrick Schwarz; Eric Dannaoui; Axel Gehl; Heike Felske-Zech; Christoph G Birngruber; Reinhard B Dettmeyer; Marcel A Verhoff Journal: Int J Legal Med Date: 2014-11-15 Impact factor: 2.686
Authors: Aaron R Farmer; Clinton K Murray; Ian R Driscoll; Brian L Wickes; Nathan Wiederhold; Deanna A Sutton; Carmita Sanders; Katrin Mende; Brent Enniss; James Feig; Anuradha Ganesan; Elizabeth A Rini; Todd J Vento Journal: J Clin Microbiol Date: 2015-04-01 Impact factor: 5.948
Authors: Anuradha Ganesan; Justin Wells; Faraz Shaikh; Philip Peterson; William Bradley; M Leigh Carson; Joseph L Petfield; Mary Klassen-Fischer; Kevin S Akers; Kevin Downing; Ralf Bialek; David R Tribble; Brian L Wickes Journal: J Clin Microbiol Date: 2019-12-23 Impact factor: 5.948
Authors: Tyler E Warkentien; Faraz Shaikh; Amy C Weintrob; Carlos J Rodriguez; Clinton K Murray; Bradley A Lloyd; Anuradha Ganesan; Deepak Aggarwal; M Leigh Carson; David R Tribble Journal: J Clin Microbiol Date: 2015-05-13 Impact factor: 5.948
Authors: Eva Kvasničková; Vít Paulíček; Martina Paldrychová; Richard Ježdík; Olga Maťátková; Jan Masák Journal: World J Microbiol Biotechnol Date: 2016-09-22 Impact factor: 3.312
Authors: Guanpingsheng Luo; Teclegiorgis Gebremariam; Karl V Clemons; David A Stevens; Ashraf S Ibrahim Journal: Vaccine Date: 2014-05-06 Impact factor: 3.641
Authors: Carlos Rodriguez; Amy C Weintrob; James R Dunne; Allison B Weisbrod; Bradley Lloyd; Tyler Warkentien; Debra Malone; Justin Wells; Clinton K Murray; William Bradley; Faraz Shaikh; Jinesh Shah; Michelle Leigh Carson; Deepak Aggarwal; David R Tribble Journal: J Trauma Acute Care Surg Date: 2014-11 Impact factor: 3.313